Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHN WILEY & SONS, INC.

(JW.A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

John Wiley & Sons : Do Bacteria in the Mouth Affect Risk of Developing Rheumatoid Arthritis?

05/05/2021 | 01:09am EDT

Investigators found similarities in the bacterial composition of the mouth among patients with early rheumatoid arthritis and those at risk of developing the disease, compared with healthy individuals who were not at risk. The findings come from a study published in Arthritis & Rheumatology.

Patients and at-risk individuals had an increased relative abundance of potentially pro- inflammatory bacteria in the mouth, suggesting a possible link between oral microbes and rheumatoid arthritis.

'Prevotella and Veillonella-both gram-negative anaerobes-were at higher relative abundance in saliva, and Veillonella was also at higher relative abundance in tongue coating, of both early rheumatoid arthritis patients and at-risk individuals compared to healthy controls,' the authors wrote.

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/art.41780

About Journal

Arthritis & Rheumatology, an official journal of the American College of Rheumatology, is a peer-reviewed publication for scientists and clinicians interested in the natural history, pathophysiology, treatment, and outcome of the rheumatic diseases. Arthritis & Rheumatology publishes the highest quality basic and clinical research related to the rheumatic diseases, encompassing a wide range of areas of investigative activity. In addition, the journal publishes review articles, editorials, and other educational material intended for both researchers and clinicians. Serving the worldwide community of rheumatology investigators and clinicians, Arthritis & Rheumatology is known internationally as a top rheumatology research journal.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Disclaimer

John Wiley & Sons Inc. published this content on 05 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 May 2021 05:08:02 UTC.


ę Publicnow 2021
All news about JOHN WILEY & SONS, INC.
05/05JOHN WILEY & SONSá : New Study Identifies Quality Measures for End-of-Life Care ..
PU
05/05JOHN WILEY & SONSá : Many Patients With Cancer Are Experiencing Loneliness and R..
PU
05/05JOHN WILEY & SONSá : Which Medications Are Most Toxic to the Liver?
PU
05/05JOHN WILEY & SONSá : Do Bacteria in the Mouth Affect Risk of Developing Rheumato..
PU
05/05JOHN WILEY & SONSá : Erythropoietin Treatments May Increase Hip Fracture Risk in..
PU
05/05JOHN WILEY & SONSá : How Accurate Are Virtual Assessments of Cognitive Function?
PU
05/05JOHN WILEY & SONSá : The Online Learning Needs of Students Across Different Grad..
PU
05/05JOHN WILEY & SONSá : English as a Medium of Instruction in Higher Education Acro..
PU
05/05JOHN WILEY & SONSá : Light Pollution at Night Affects the Calls of Migratory Bir..
PU
05/05JOHN WILEY & SONSá : New Tool Offers Personalized, Low Environmental Impact, Hea..
PU
More news
Financials (USD)
Sales 2021 1 904 M - -
Net income 2021 139 M - -
Net Debt 2021 938 M - -
P/E ratio 2021 24,9x
Yield 2021 2,22%
Capitalization 3 435 M 3 435 M -
EV / Sales 2021 2,30x
EV / Sales 2022 2,19x
Nbr of Employees 6 900
Free-Float 52,3%
Chart JOHN WILEY & SONS, INC.
Duration : Period :
John Wiley & Sons, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHN WILEY & SONS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 55,33 $
Last Close Price 61,72 $
Spread / Highest target 0,45%
Spread / Average Target -10,3%
Spread / Lowest Target -22,2%
EPS Revisions
Managers and Directors
NameTitle
Brian A. Napack President, Chief Executive Officer & Director
John Anthony Kritzmacher Chief Financial Officer & Executive VP-Operations
Jesse C. Wiley Non-Executive Chairman
Aref Matin Chief Technology Officer & Executive VP
Raymond W. McDaniel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHN WILEY & SONS, INC.34.17%3 414
S&P GLOBAL INC.15.51%91 465
RELX PLC1.79%49 331
THOMSON REUTERS CORPORATION9.91%46 733
MSCI INC.3.26%38 004
EQUIFAX INC.20.94%28 846